The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The hepatic apelin system: A new therapeutic target for liver disease†
Open accessAbstract
UNLABELLED: Apelin is a peptide that plays an important role in heart physiology and pathophysiology, inflammation, and angiogenesis. We evaluated whether the endogenous apelin system is involved in the pathogenesis of the hepatic remodeling and cardiovascular and renal complications occurring in advanced liver disease. The circulating levels of apelin, the messenger RNA (mRNA) and protein expression of apelin and apelin receptor, the immunohistological detection of apelin and apelin receptor, and the effects induced by the chronic administration of an apelin receptor antagonist on fibrosis and vessel density were evaluated in rats with cirrhosis and ascites and in control rats. The serum levels of apelin in patients with cirrhosis were also measured. Apelin levels were higher in rats with cirrhosis than in controls. Apelin mRNA showed a four-fold rise only in hepatic tissue, but not in the lung, heart, or kidney of rats with cirrhosis. These animals also showed hepatic apelin receptor mRNA levels 300 times higher than controls. Apelin was highly expressed by stellate cells, whereas apelin receptor was overexpressed in the hepatic parenchyma of animals with cirrhosis. Rats with cirrhosis treated with the apelin receptor antagonist showed diminished hepatic fibrosis and vessel density, improved cardiovascular performance, and renal function and lost ascites. Human patients also showed a marked increase in apelin levels. CONCLUSION: The selective hepatic activation of the apelin system, together with the drop in fibrosis and neoangiogenesis and the improvement in cardiovascular and excretory function resulting from apelin receptor blockade, points to the hepatic apelin system as a novel therapeutic target in liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Apelin has been shown to be involved in glucose metabolism disorders and in hepatic fibrosis [52,53].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [53]
Citations
Cites
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ Receptor
Tatemoto, K., Hosoya, M., Habata, Y., Fujii, R., Kakegawa, T., Zou, M.-X., Kawamata, Y., Fukusumi, S., Hinuma, S., Kitada, C., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9489 · Cited by 1,684
Apelin, a Newly Identified Adipokine Up-Regulated by Insulin and Obesity
Boucher, J., Masri, B., Daviaud, D., Gesta, S., Guigné, C., Mazzucotelli, A., Castan-Laurell, I., Tack, I., Knibiehler, B., Carpéné, C., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1427 · Cited by 910
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
Tatemoto, K., Takayama, K., Zou, M.-X., Kumaki, I., Zhang, W. Y., KUMANO, K., & Fujimiya, M. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00236-1 · Cited by 640
Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility
Szokodi, I., Tavi, P., Földes, G., Voutilainen-Myllylä, S., Ilves, M., Tokola, H., Pikkarainen, S., Piuhola, J., Rysä, J., Tóth, M., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000033522.37861.69 · Cited by 625
Molecular properties of apelin: tissue distribution and receptor binding
Kawamata, Y., Habata, Y., Fukusumi, S., Hosoya, M., Fujii, R., Hinuma, S., Nishizawa, N., Kitada, C., Onda, H., Nishimura, O., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00143-9 · Cited by 521
Molecular and Functional Characteristics of APJ
Hosoya, M., Kawamata, Y., Fukusumi, S., Fujii, R., Habata, Y., Hinuma, S., Kitada, C., Honda, S., Kurokawa, T., Onda, H., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908417199 · Cited by 488
Ishida, J., Hashimoto, T., Hashimoto, Y., Nishiwaki, S., Iguchi, T., Harada, S., Sugaya, T., Matsuzaki, H., Yamamoto, R., Shiota, N., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404149200 · Cited by 411
Mota, N. D., Goazigo, A. R.-L., Messari, S. E., Chartrel, N., Roesch, D. M., Dujardin, C., Kordon, C., Vaudry, H., Moos, F., & Llorens‐Cortés, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403518101 · Cited by 377
Cox, C. M., D'Agostino, S. L., Miller, M. K., Heimark, R. L., & Krieg, P. A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.04.452 · Cited by 338
Cited by
Sorted by citations
Adipokines in liver diseases #
Marra, F., & Bertolani, C. (2009) · Hepatology · doi:10.1002/hep.23046 · Cited by 468
Adipokines in nonalcoholic fatty liver disease
Pοlyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2015.11.006 · Cited by 369
The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis
O’Carroll, A., Lolait, S. J., Harris, L. E., & Pope, G. R. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0227 · Cited by 339
Adipokines – removing road blocks to obesity and diabetes therapy
Blüher, M. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.005 · Cited by 273
Chakaroun, R., Raschpichler, M., Klöting, N., Oberbach, A., Flehmig, G., Kern, M., Schön, M. R., Shang, E., Lohmann, T., Dreßler, M., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.10.008 · Cited by 234
Clinical Relevance of Adipokines
Blüher, M. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.5.317 · Cited by 210
Pitkin, S. L., Maguire, J. J., Bonner, T. I., & Davenport, A. P. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002949 · Cited by 198
Cellular and molecular mechanisms in liver fibrogenesis
Novo, E., Cannito, S., Paternostro, C., Bocca, C., Miglietta, A., & Parola, M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.02.015 · Cited by 194
Lee, M.-W., Lee, M., & Oh, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060854 · Cited by 192
Adipokines as Drug Targets in Diabetes and Underlying Disturbances
Andrade‐Oliveira, V., Câmara, N. O. S., & Moraes‐Vieira, P. M. (2015) · Journal of Diabetes Research · doi:10.1155/2015/681612 · Cited by 165
Adipose Organ Development and Remodeling
Cinti, S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170042 · Cited by 197
Free radicals and male reproduction.
Agarwal, A. K., & Allamaneni, S. S. R. (2011) · PubMed · Cited by 154
Angiogenesis and liver fibrosis
Elpek, G. Ö. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.377 · Cited by 159
Angiogenesis and Fibrogenesis in Chronic Liver Diseases
Bocca, C., Novo, E., Miglietta, A., & Parola, M. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.06.011 · Cited by 157
Monocyte-endothelial cell interactions in vascular and tissue remodeling
Medrano-Bosch, M., Simón-Codina, B., Jiménez, W., Edelman, E. R., & Melgar‐Lesmes, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1196033 · Cited by 168
Self-citationApelin, a promising target for type 2 diabetes treatment?
Castan‐Laurell, I., Dray, C., Knauf, C., Kunduzova, O., & Valet, P. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.02.005 · Cited by 150
Zhu, S., Sun, F., Li, W., Cao, Y., Wang, C., Wang, Y., Dong, L., Zhang, R., Zhang, S., Wang, H., et al. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0799-0 · Cited by 140
Adipocytokines and hepatic fibrosis
Saxena, N. K., & Anania, F. A. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.01.002 · Cited by 140
Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice #
Österreicher, C. H., Taura, K., Minicis, S. D., Seki, E., Penz-Österreicher, M., Kodama, Y., Kluwe, J., Schuster, M., Oudit, G. Y., Penninger, J. M., et al. (2009) · Hepatology · doi:10.1002/hep.23104 · Cited by 133
Krist, J., Wieder, K., Klöting, N., Oberbach, A., Kralisch, S., Wiesner, T., Schön, M. R., Gärtner, D., Dietrich, A., Shang, E., et al. (2013) · Obesity Facts · doi:10.1159/000348667 · Cited by 124
Read, C., Nyimanu, D., Williams, T., Huggins, D. J., Šulentić, P., Macrae, R. G. C., Yang, P. B., Glen, R. C., Maguire, J. J., & Davenport, A. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.119.017533 · Cited by 130
Apelin Attenuates Hyperoxic Lung and Heart Injury in Neonatal Rats
de Visser, Y. P., Walther, F. J., Laghmani, E. H., van der Laarse, A., & Wagenaar, G. T. M. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1361oc · Cited by 97
Apelinergic System Structure and Function
Shin, K., Kenward, C., & Rainey, J. K. (2017) · Comprehensive physiology · doi:10.1002/cphy.c170028 · Cited by 95
Rai, R., Ghosh, A. K., Eren, M., Mackie, A. R., Levine, D. C., Kim, S., Cedernaes, J., Ramirez, V., Procissi, D., Smith, L. H., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.057 · Cited by 94
Taveau, C., Chollet, C., Waeckel, L., Desposito, D., Bichet, D. G., Arthus, M.-F., Magnan, C., Philippe, E., Paradis, V., Foufelle, F., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3496-9 · Cited by 86
Apelin/APJ system: A novel promising therapy target for pathological angiogenesis
Wu, L., Chen, L., & Li, L. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.12.023 · Cited by 86
Apelin/APJ system in inflammation
Wang, X., Zhang, L., Li, P., Zheng, Y., Yang, Y., & Ji, S. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108822 · Cited by 83
Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma
Li, H. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1842732 · Cited by 76
Tiani, C., García‐Pras, E., Mejías, M., Gottardi, A. D., Berzigotti, A., Bosch, J., & Fernández, M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.09.019 · Cited by 77
Melgar‐Lesmes, P., Pauta, M., Reichenbach, V., Casals, G., Ros, J., Bataller, R. A., Morales‐Ruiz, M., & Jiménez, W. (2011) · Gut · doi:10.1136/gut.2010.234690 · Cited by 69
Self-citationApelin and APJ, a novel critical factor and therapeutic target for atherosclerosis
Lv, D., Li, H., & Chen, L. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt040 · Cited by 68
Reichenbach, V., Ros, J., Fernández‐Varo, G., Casals, G., Melgar‐Lesmes, P., Campos, T., Makriyannis, A., Morales‐Ruiz, M., & Jiménez, W. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188078 · Cited by 64
Self-citationApelin Mediates the Induction of Profibrogenic Genes in Human Hepatic Stellate Cells
Melgar‐Lesmes, P., Casals, G., Pauta, M., Ros, J., Reichenbach, V., Bataller, R. A., Morales‐Ruiz, M., & Jiménez, W. (2010) · Endocrinology · doi:10.1210/en.2010-0754 · Cited by 63
Self-citationInhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth
Hall, C. M., Ehrlich, L., Venter, J. K., O’Brien, A., White, T. K., Zhou, T., Dang, T., Meng, F., Invernizzi, P., Bernuzzi, F., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.025 · Cited by 63
Apelin Serum Level in Egyptian Patients with Chronic Hepatitis C
EL-Mesallamy, H. O., Hamdy, N. Μ., Rizk, H. H., & El‐Zayadi, A. (2011) · Mediators of Inflammation · doi:10.1155/2011/703031 · Cited by 60
The apelin–APJ axis: A novel potential therapeutic target for organ fibrosis
Huang, S., Chen, L., Lu, L., & Li, L. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.025 · Cited by 54
The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis
Méndez‐Sánchez, N., Valencia-Rodríguez, A., Coronel-Castillo, C. E., Vera-Barajas, A., Contreras-Carmona, J., Ponciano‐Rodríguez, G., & Zamora‐Valdés, D. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.184 · Cited by 55
Apelin/APJ system: A key therapeutic target for liver disease
Lv, S., Cui, B., Chen, W., & Wang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.22841 · Cited by 52
The protective effect of apelin on ischemia/reperfusion injury
Yang, Y., Lv, S., Lyu, S.-K., Wu, D., & Chen, Q. (2014) · Peptides · doi:10.1016/j.peptides.2014.11.001 · Cited by 52
The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis
Wang, L., Diao, Z.-L., Zhang, D., Zheng, J., Zhang, Q., Ding, J., & Liu, W. (2014) · Amino Acids · doi:10.1007/s00726-014-1826-8 · Cited by 51
The apelinergic system: a promising therapeutic target
Falcão‐Pires, I., Ladeiras‐Lopes, R., & Leite-Moreira, A. F. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003752743 · Cited by 50
Function and regulation of apelin/APJ system in digestive physiology and pathology
Huang, Z., Luo, X., Liu, M., & Chen, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27720 · Cited by 51
The Adipokines in Cancer Cachexia
Mannelli, M., Gamberi, T., Magherini, F., & Fiaschi, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144860 · Cited by 53
Kalafateli, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i10.3020 · Cited by 50
Blockade of the Renin-Angiotensin System Ameliorates Apelin Production in 3T3-L1 Adipocytes
Hung, W., Hsieh, T., Lin, T. H., Chou, P.-C., Hsiao, P., Lin, K., & Shin, S. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6274-4 · Cited by 50
Lower serum apelin levels in women with polycystic ovary syndrome
Chang, C., Tsai, Y.-C., Lee, C., Chan, T., Wang, S., & Su, J.-H. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.04.044 · Cited by 46
Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells
Wang, Y., Song, J., Bian, H., Bo, J., Lv, S., Pan, W., & Lv, X. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03581-0 · Cited by 45
Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis
Melgar‐Lesmes, P., Perramón, M., & Jiménez, W. (2019) · Cells · doi:10.3390/cells8111311 · Cited by 45
Self-citationThe Role of the Apelin/APJ System in the Regulation of Liver Disease
Lv, X., Kong, J., Chen, W., & Wang, Y. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00221 · Cited by 42
Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases.
Cannito, S., Paternostro, C., Busletta, C., Bocca, C., Colombatto, S., Miglietta, A., Novo, E., & Parola, M. (2014) · PubMed · doi:10.14670/hh-29.33 · Cited by 41
Chen, L., Zhou, T., White, T. K., O’Brien, A., Chakraborty, S., Liangpunsakul, S., Yang, Z., Kennedy, L. L., Saxena, R., Wu, C., et al. (2020) · Hepatology · doi:10.1002/hep.31545 · Cited by 41
Plasma apelin levels in subjects with nonalcoholic fatty liver disease
Erçin, C. N., Doğru, T., Tapan, S., Kara, M., Haymana, C., Karadurmuş, N., Karslıoğlu, Y., & Açıkel, C. (2010) · Metabolism · doi:10.1016/j.metabol.2009.10.019 · Cited by 40
Lim, Y. L., Choi, E. H., Jang, Y. O., Cho, Y. Z., Kang, Y. S., Baik, S. K., Kwon, S. O., & Kim, M. Y. (2015) · Gut and Liver · doi:10.5009/gnl14345 · Cited by 38
Son, J. S., Kim, H., Son, Y., Lee, H., Chae, S. A., Seong, J. K., & Song, W. J. (2017) · Muscle & Nerve · doi:10.1002/mus.25596 · Cited by 38
Headgroup-Dependent Membrane Catalysis of Apelin−Receptor Interactions Is Likely
Langelaan, D. N., & Rainey, J. K. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp904562q · Cited by 37
Angiogenesis and portal-systemic collaterals in portal hypertension
Gana, J. C., Serrano, C. A., & Ling, S. C. (2016) · Annals of Hepatology · doi:10.5604/16652681.1198799 · Cited by 35
Sağıroğlu, T., Torun, N., Yağcı, M. A., Yalta, T. D., Sağıroğlu, G., & Oğuz, S. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.499 · Cited by 35
Yokomori, H., Oda, M., Yoshimura, K., Machida, S., Kaneko, F., & Hibi∥, T. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0296-3 · Cited by 33
Huang, J., Kang, S., Park, S.-J., & Im, D. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.08.003 · Cited by 31
Modulation of Liver Fibrosis by Adipokines
Marra, F., Navari, N., Vivoli, E., Galastri, S., & Provenzano, A. (2011) · Digestive Diseases · doi:10.1159/000329799 · Cited by 30
Bertrand, C., Pradère, J., Geoffre, N., Deleruyelle, S., Masri, B., Personnaz, J., Gonidec, S. L., Batut, A., Louche, K., Moro, C., et al. (2018) · Endocrine · doi:10.1007/s12020-018-1536-1 · Cited by 30
Serum Apelin and Obesity-Related Complications in Egyptian Children
Wakeel, M. A. E., El-Kassas, G. M., Kamhawy, A. H., Galal, E. M., Nassar, M. S., Hammad, E. M., & El-Zayat, S. R. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.312 · Cited by 28
Involvement of the apelin receptor APJ in Fas‐induced liver injury
Yasuzaki, H., Yoshida, S., Hashimoto, T., Shibata, W., Inamori, M., Toya, Y., Tamura, K., Maeda, S., & Umemura, S. (2012) · Liver International · doi:10.1111/liv.12006 · Cited by 27
Importance of adipokines in glucose homeostasis
Blüher, M. (2013) · Diabetes Management · doi:10.2217/dmt.13.35 · Cited by 26
Abd-Elbaky, A. E., Abo–Elmatty, D. M., Mesbah, N. M., & Ibrahim, S. M. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0416-y · Cited by 23
Chen, W., Oue, T., Ueno, T., Uehara, S., Usui, N., & Fukuzawa, M. (2012) · Pediatric Surgery International · doi:10.1007/s00383-012-3210-7 · Cited by 23
Babaei, P., Dastras, A., Tehrani, B. S., & Roudbaneh, S. P. (2017) · Journal of Menopausal Medicine · doi:10.6118/jmm.2017.23.3.182 · Cited by 23
Son, J. S., Chae, S. A., Park, B. I., Du, M., & Song, W. (2019) · Endocrinología, Diabetes y Nutrición · doi:10.1016/j.endinu.2018.12.005 · Cited by 21
Fernández‐Varo, G., Oró, D., Cable, E. E., Reichenbach, V., Carvajal, S., de la Presa, B. G., Wiśniewski, K., Ginès, P., Harris, G., & Jiménez, W. (2015) · Hepatology · doi:10.1002/hep.28250 · Cited by 21
Self-citationYokomori, H., Oda, M., Yoshimura, K., & Hibi∥, T. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00945.x · Cited by 19
Mechanism of KLF4 Protection against Acute Liver Injury via Inhibition of Apelin Signaling
Ji, W., Shi, H., Shen, H., Kong, J., Song, J.-Y., Bian, H.-Y., & Lv, X.-R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6140360 · Cited by 15
Effect of Leptin and Apelin Preconditioning on Hepatic Ischemia Reperfusion Injury in Rats
Sağıroğlu, T., Aksoy, M. B., Sağıroğlu, G., Tozkır, H., Oğuz, S., Yalta, T. D., Yağcı, M. A., & Sezer, A. (2012) · Indian Journal of Surgery · doi:10.1007/s12262-012-0676-4 · Cited by 19
Farid, R. M., Abu-Zeid, R. M., & El-Tawil, A. (2014) · PubMed Central · Cited by 19
Ibrahim, R. S., El-Mezayen, N. S., & El‐Banna, A. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-15958-1 · Cited by 19
Apelinergic System Structure and Function
Shin, K., Kenward, C., & Rainey, J. K. (2018) · Comprehensive physiology · doi:10.1002/j.2040-4603.2018.tb00012.x · Cited by 17
Do adipokines link obesity to its related metabolic and cardiovascular diseases?
Blüher, M. (2010) · Clinical Lipidology · doi:10.2217/clp.09.86 · Cited by 17
Pathophysiology of Portal Hypertension
Morales‐Ruiz, M., Rodríguez‐Vita, J., Ribera, J., & Jiménez, W. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_144 · Cited by 17
Self-citationJia, H., Aw, W., Saito, K., Hanate, M., Hasebe, Y., & Kato, H. (2014) · Scientific Reports · doi:10.1038/srep07473 · Cited by 17
Antiangiogenic therapies in portal hypertension: A breakthrough in hepatology
Rosmorduc, O. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2010.05.007 · Cited by 17
Ilaghi, M., Soltanizadeh, A., Amiri, S., Kohlmeier, K. A., & Shabani, M. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175353 · Cited by 15
Owen, N. E., Nyimanu, D., Kuc, R. E., Upton, P. D., Morrell, N. W., Alexander, G., Maguire, J. J., & Davenport, A. P. (2020) · Peptides · doi:10.1016/j.peptides.2020.170440 · Cited by 14
Predictive and Diagnostic Value of Serum Adipokines in Pregnant Women with Intrahepatic Cholestasis
Yurtçu, N., Çalışkan, C. S., GÜVEY, H., Çelik, S., Hatırnaz, Ş., & Tinelli, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042254 · Cited by 14
Apelin in epiretinal membranes of patients with proliferative diabetic retinopathy.
Lü, Q., Ma, Y., Xu, Y.-S., & Jiang, Y. (2014) · PubMed Central · Cited by 13
Type of arteriovenous fistula, NYHA class and apelin in hemodialyzed patients
Małyszko, J., Koźmiński, P., Małyszko, J. S., & Myśliwiec, M. (2009) · International Urology and Nephrology · doi:10.1007/s11255-009-9667-1 · Cited by 11
Cytokine Production and Signaling in Stellate Cells
Marra, F., & Caligiuri, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00005-1 · Cited by 11
Bayraktar, B., Tekçe, E., Aksakal, V., Gül, M., Takma, Ç., Bayraktar, S., Bayraktar, F. G., & Eser, G. (2020) · Italian Journal of Animal Science · doi:10.1080/1828051x.2020.1778548 · Cited by 11
Lv, S., Zhang, X., Zhou, Y., Feng, Y., Yang, Y., & Wang, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01335 · Cited by 10
Emam, M. N., & Gheit, R. E. A. E. (2015) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2015.11.003 · Cited by 8
Adipokines in Nonalcoholic Fatty Liver Disease
Baranova, A. V., Birerdinc, A., & Younossi, Z. M. (2014) · Humana Press eBooks · doi:10.1007/978-1-62703-770-9_17 · Cited by 8
Aktan, A. K., & Kutlay, Ö. (2023) · Protein and Peptide Letters · doi:10.2174/0929866530666230824142516 · Cited by 7
Huang, Y. G., Zhang, S., Weng, J., Huang, D., & Gu, W. (2022) · Open Medicine · doi:10.1515/med-2022-0481 · Cited by 6
Pathophysiology of Portal Hypertension
Morales‐Ruiz, M., Rodríguez‐Vita, J., Ribera, J., & Jiménez, W. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_144-1 · Cited by 6
Self-citationDoğru, T., Erçin, C. N., Erdem, G., Kılcıler, G., & Tapan, S. (2008) · Hepatology · doi:10.1002/hep.22688 · Cited by 5
Apelin C-Terminal Fragments: Biological Properties and Therapeutic Potential
Pisarenko, O. I., & Studneva, I. M. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923110160 · Cited by 4
Ibrahim, S. M., & Bastawy, A. A. (2019) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666191210122851 · Cited by 4
Balta, Ş., Demırkol, S., Celık, T., Ünlü, M., Küçük, U., & Arslan, Z. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12120 · Cited by 4
Karampatsou, S., Paltoglou, G., Genitsaridi, S. M., Kassari, P., & Charmandari, E. (2024) · Nutrients · doi:10.3390/nu16213646 · Cited by 3
Slotki, I. N., & Skorecki, K. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10014-4 · Cited by 3
Kälin, S., & Kälin, R. E. (2016) · Energy balance and cancer · doi:10.1007/978-3-319-41677-9_7 · Cited by 3
Ibrahim, S. M. (2015) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2015.02.00018 · Cited by 3
Metadata
- Authors
- Principe, A., Melgar‐Lesmes, P., Fernández‐Varo, G., del Arbol, L. R., Ros, J., Morales‐Ruiz, M., Bernardi, M., Arroyo, V., & Jiménez, W.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Corresponding author
- Jiménez, Wladimiro
- ORCID
- Venue
- Hepatology
- Published
- 2008-10
- Volume
- 48
- Issue
- 4
- Pages
- 1193-1201
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1978999795
- Cited by
- 127
- References
- 32
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 6 · 2022: 7 · 2020: 11 · 2019: 9 · 2018: 7 · 2017: 7 · 2016: 6 · 2015: 17 · 2014: 10 · 2013: 7 · 2012: 9
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Apelin-related biomedical research
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- apelin, apelin receptor, liver cirrhosis, liver fibrosis, ascites, hepatic stellate cells, neoangiogenesis, cardiovascular complications, renal function, advanced liver disease, therapeutic target
- MeSH terms
- Apelin, Adult, Animals, Blood Pressure, Carbon Tetrachloride, Carrier Proteins, Disease Models, Animal, Female, Humans, Liver, Liver Cirrhosis, Male, Middle Aged, Renin-Angiotensin System, RNA, Messenger, Sympathetic Nervous System, Vascular Resistance, Case-Control Studies, Rats, Wistar, Intercellular Signaling Peptides and Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review